Patent ID: 6596700
Filing Date: 2003-07-22
Classification: A61K,A61P,Y10S

Abstract:
A method for treating a host infected with hepatitis D virus comprising administering an effective treatment amount of 2â€²-deoxy-&bgr;-L-erythro-pentofuranonucleoside of the formula: or a pharmaceutically acceptable salt thereof, whereinR1 is selected from the group consisting of H, straight chained, branched or cyclic alkyl, CO-alkyl, CO-aryl, CO-alkoxyalkyl, CO-aryloxyalkyl, CO-substituted aryl, alkylsulfonyl, arylsulfonyl, aralkylsulfonyl, amino acid residue, mono, di, or triphosphate, or a phosphate derivative; and BASE is a purine or pyrimidine base that may optionally be substituted.